Hantz Financial Services’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,100
| Closed | -$88K | – | 1068 |
|
|
2024
Q1 | $88K | Hold |
1,100
| – | – | ﹤0.01% | 614 |
|
|
2023
Q4 | $88K | Hold |
1,100
| – | – | ﹤0.01% | 609 |
|
|
2023
Q3 | $77K | Hold |
1,100
| – | – | ﹤0.01% | 606 |
|
|
2023
Q2 | $79K | Hold |
1,100
| – | – | ﹤0.01% | 585 |
|
|
2023
Q1 | $68K | Hold |
1,100
| – | – | ﹤0.01% | 595 |
|
|
2022
Q4 | $85K | Hold |
1,100
| – | – | ﹤0.01% | 577 |
|
|
2022
Q3 | $49K | Hold |
1,100
| – | – | ﹤0.01% | 595 |
|
|
2022
Q2 | $42K | Buy |
+1,100
| New | +$42K | ﹤0.01% | 602 |
|